Search

Jared Barsky

Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1628
Total Applications
964
Issued Applications
443
Pending Applications
93
Abandoned Applications
428

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11418995 [patent_doc_number] => 20170027139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'ANIMAL MODELS OF AGE-RELATED DISORDERS AND AGE-SENSITIVE TRAITS ASSOCIATED WITH SENESCENCE-INDUCING STIMULI AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/067543 [patent_app_country] => US [patent_app_date] => 2016-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067543 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/067543
Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells Mar 10, 2016 Issued
Array ( [id] => 11022892 [patent_doc_number] => 20160219847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'COMMON LIGHT CHAIN MOUSE' [patent_app_type] => utility [patent_app_number] => 15/056713 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 53724 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056713 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/056713
COMMON LIGHT CHAIN MOUSE Feb 28, 2016 Abandoned
Array ( [id] => 15309499 [patent_doc_number] => 10519440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases [patent_app_type] => utility [patent_app_number] => 15/048964 [patent_app_country] => US [patent_app_date] => 2016-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 45 [patent_no_of_words] => 15619 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048964 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/048964
Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases Feb 18, 2016 Issued
Array ( [id] => 11625137 [patent_doc_number] => 20170135326 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-05-18 [patent_title] => 'NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES' [patent_app_type] => utility [patent_app_number] => 14/961642 [patent_app_country] => US [patent_app_date] => 2015-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 107 [patent_no_of_words] => 66245 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961642 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/961642
Non-human animals with modified immunoglobulin heavy chain sequences Dec 6, 2015 Issued
Array ( [id] => 11625137 [patent_doc_number] => 20170135326 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-05-18 [patent_title] => 'NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES' [patent_app_type] => utility [patent_app_number] => 14/961642 [patent_app_country] => US [patent_app_date] => 2015-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 107 [patent_no_of_words] => 66245 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961642 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/961642
Non-human animals with modified immunoglobulin heavy chain sequences Dec 6, 2015 Issued
Array ( [id] => 10706839 [patent_doc_number] => 20160052986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'HUMANIZED IL-7 RODENTS' [patent_app_type] => utility [patent_app_number] => 14/937270 [patent_app_country] => US [patent_app_date] => 2015-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8713 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937270 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/937270
HUMANIZED IL-7 RODENTS Nov 9, 2015 Abandoned
Array ( [id] => 12058665 [patent_doc_number] => 20170335009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'TETRAVALENT TLR9 BISPECIFIC ANTIBODY' [patent_app_type] => utility [patent_app_number] => 15/522955 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10421 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522955 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/522955
TETRAVALENT TLR9 BISPECIFIC ANTIBODY Oct 29, 2015 Abandoned
Array ( [id] => 11236164 [patent_doc_number] => 09462794 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Non-human animals having a humanized signal-regulatory protein gene' [patent_app_type] => utility [patent_app_number] => 14/882531 [patent_app_country] => US [patent_app_date] => 2015-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17576 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882531 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/882531
Non-human animals having a humanized signal-regulatory protein gene Oct 13, 2015 Issued
Array ( [id] => 17936397 [patent_doc_number] => 11470826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-18 [patent_title] => Method of conveniently producing genetically modified non-human mammal with high efficiency [patent_app_type] => utility [patent_app_number] => 15/527085 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6249 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527085 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/527085
Method of conveniently producing genetically modified non-human mammal with high efficiency Oct 5, 2015 Issued
Array ( [id] => 18545491 [patent_doc_number] => 11718832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors [patent_app_type] => utility [patent_app_number] => 15/517014 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23935 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517014 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/517014
Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors Oct 5, 2015 Issued
Array ( [id] => 10679561 [patent_doc_number] => 20160025706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY' [patent_app_type] => utility [patent_app_number] => 14/875725 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4546 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14875725 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/875725
METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY Oct 5, 2015 Abandoned
Array ( [id] => 11656076 [patent_doc_number] => 09669058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Engineering and delivery of therapeutic compositions of freshly isolated cells' [patent_app_type] => utility [patent_app_number] => 14/834932 [patent_app_country] => US [patent_app_date] => 2015-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 15121 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834932 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/834932
Engineering and delivery of therapeutic compositions of freshly isolated cells Aug 24, 2015 Issued
Array ( [id] => 12057181 [patent_doc_number] => 20170333524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'MOLECULAR CONSTRUCTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/327984 [patent_app_country] => US [patent_app_date] => 2015-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13827 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327984 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/327984
Molecular constructs and uses thereof Jul 21, 2015 Issued
Array ( [id] => 11668468 [patent_doc_number] => 20170157188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS' [patent_app_type] => utility [patent_app_number] => 15/325562 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18701 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325562 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/325562
Oncolytic virus for expression of immune checkpoint modulators Jul 15, 2015 Issued
Array ( [id] => 10466356 [patent_doc_number] => 20150351371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'Hybrid Light Chain Mice' [patent_app_type] => utility [patent_app_number] => 14/800257 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26462 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800257 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/800257
Hybrid light chain mice Jul 14, 2015 Issued
Array ( [id] => 10421135 [patent_doc_number] => 20150306147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'ISOLATED LIVER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 14/795195 [patent_app_country] => US [patent_app_date] => 2015-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28540 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795195 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/795195
Isolated liver stem cells Jul 8, 2015 Issued
Array ( [id] => 10411746 [patent_doc_number] => 20150296755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS' [patent_app_type] => utility [patent_app_number] => 14/792208 [patent_app_country] => US [patent_app_date] => 2015-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8272 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14792208 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/792208
Transgenic animals capable of being induced to delete senescent cells Jul 5, 2015 Issued
Array ( [id] => 10387990 [patent_doc_number] => 20150272997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'Mesenchymal Stem Cells and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 14/739924 [patent_app_country] => US [patent_app_date] => 2015-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9886 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739924 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/739924
Mesenchymal Stem Cells and Uses Therefor Jun 14, 2015 Abandoned
Array ( [id] => 11568854 [patent_doc_number] => 20170107498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-20 [patent_title] => 'NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/316098 [patent_app_country] => US [patent_app_date] => 2015-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13288 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316098 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/316098
NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING IMMORTALIZED LYMPHOBLASTOID CELL LINES TO INDUCED PLURIPOTENT STEM CELLS Jun 4, 2015 Abandoned
Array ( [id] => 10361971 [patent_doc_number] => 20150246976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'Hybrid Light Chain Mice' [patent_app_type] => utility [patent_app_number] => 14/715145 [patent_app_country] => US [patent_app_date] => 2015-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26436 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715145 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/715145
Hybrid light chain mice May 17, 2015 Issued
Menu